• Home >
  • Vital Signs - Over the Patent Cliff: Suing the FDA is the Latest Action by Branded and Generics Pharmaceutical Companies Battling for Market Opportunity

Vital Signs - Over the Patent Cliff: Suing the FDA is the Latest Action by Branded and Generics Pharmaceutical Companies Battling for Market Opportunity

07-Mar-2013  /  Research Code: 9561-00-F3-00-00  /  SKU: LS00245-NA-MR_17659  /  
Region: North America

Regular Price: USD 1,500

Special Price USD 1,275

15% OFF

* Required Fields

Regular Price: USD 1,500

Special Price USD 1,275

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on March 7, 2013, provides an insight in to battle between FDA and branded and generic pharmaceutical companies.

Additionally, a company spotlight is provided for PLC Diagnostics. PLC Diagnostics is an early stage startup, developing the next generation of handheld point-of-care testing devices.

Table of Contents

Vital Signs - Over the Patent Cliff: Suing the FDA is the Latest Action by Branded and Generics Pharmaceutical Companies Battling for Market OpportunityVital Signs: 7 March 2013This week's issue




Related Research

An End User Perspective on Navigating Digital Transformation, Global, 2017

Release Date : 20-Oct-17

Region : North America

End User Priorities for Customer Engagement, Global, 2017

Release Date : 16-Oct-17

Region : North America

An End User Perspective on Workplace Communications and Collaboration, Global, 2017

Release Date : 13-Oct-17

Region : North America

An End User Perspective on Navigating Digital Transformation in IT and Communications, Global, 2017

Release Date : 13-Oct-17

Region : North America

An End User Perspective on Navigating Digital Transformation in Finance, Banking, and Insurance, Global, 2017

Release Date : 12-Oct-17

Region : North America

Why Frost & Sullivan

Vision & Strategy

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Brand & Demand

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Technology & IP

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

Global Prespective

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.